Global Drug Management System Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02256337

Publication Date:

February 28, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Drug Management System market size is predicted to grow from US$ 3318 million in 2025 to US$ 6274 million in 2031; it is expected to grow at a CAGR of 11.2% from 2025 to 2031.
The drug management system is a digital platform designed for medical institutions, drug manufacturers, drug wholesalers and retail pharmacies, etc., which aims to efficiently and accurately manage the entire process of drug procurement, inventory, distribution, sales and traceability. The system ensures the security and compliance of the drug supply chain by recording and monitoring information such as drug batches, expiration dates, inventory status and sales flows. At the same time, the drug management system usually also integrates data analysis functions, which can generate inventory reports, sales trend analysis, drug usage and reminders of approaching expiration dates, etc., to help managers optimize drug inventory control and procurement decisions, reduce waste and capital occupation. In addition, the system can achieve interface docking with national drug regulatory agencies, comply with drug traceability and regulatory requirements, and improve the transparency and standardization of drug management, thereby better ensuring drug safety.
The drug management system plays an indispensable role in modern medical care and the drug supply chain. It significantly improves the efficiency and safety of the drug supply chain through intelligent management of drug circulation and inventory. With the help of the drug management system, medical institutions and pharmaceutical companies can achieve real-time update and tracking of drug information, ensure the transparency of the entire process from drug production to patient hands, and prevent expired and counterfeit drugs from entering the market. At the same time, the system's inventory warning, intelligent procurement suggestions and data analysis functions help optimize drug inventory allocation and procurement costs, improve drug availability, and ultimately ensure the safety and timeliness of patient medication. As the digitalization process of the pharmaceutical industry accelerates, the value of the drug management system in meeting compliance requirements, improving operational efficiency and protecting public health will become increasingly apparent.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淒rug Management System Industry Forecast鈥� looks at past sales and reviews total world Drug Management System sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Management System sales for 2025 through 2031. With Drug Management System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Management System industry.
This Insight Report provides a comprehensive analysis of the global Drug Management System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Management System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug Management System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Management System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Management System.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Management System market by product type, application, key players and key regions and countries.
Segmentation by Type:
Internal Solutions
Web-Based
Cloud Based
Segmentation by Application:
Hospital
Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Veradigm
Becton, Dickinson and Company
GE Healthcare
McKesson
Oracle Health
Omnicell
Chongqing Houjie Pharmaceutical Group
Qingdao Yunuo Network Information
Guangzhou Yida Computer Technology
Haihaidian Software

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Management System Market Size (2020-2031)
2.1.2 Drug Management System Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Drug Management System by Country/Region (2020, 2024 & 2031)
2.2 Drug Management System Segment by Type
2.2.1 Internal Solutions
2.2.2 Web-Based
2.2.3 Cloud Based
2.3 Drug Management System Market Size by Type
2.3.1 Drug Management System Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Drug Management System Market Size Market Share by Type (2020-2025)
2.4 Drug Management System Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Others
2.5 Drug Management System Market Size by Application
2.5.1 Drug Management System Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Drug Management System Market Size Market Share by Application (2020-2025)
3 Drug Management System Market Size by Player
3.1 Drug Management System Market Size Market Share by Player
3.1.1 Global Drug Management System Revenue by Player (2020-2025)
3.1.2 Global Drug Management System Revenue Market Share by Player (2020-2025)
3.2 Global Drug Management System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Management System by Region
4.1 Drug Management System Market Size by Region (2020-2025)
4.2 Global Drug Management System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug Management System Market Size Growth (2020-2025)
4.4 APAC Drug Management System Market Size Growth (2020-2025)
4.5 Europe Drug Management System Market Size Growth (2020-2025)
4.6 Middle East & Africa Drug Management System Market Size Growth (2020-2025)
5 Americas
5.1 Americas Drug Management System Market Size by Country (2020-2025)
5.2 Americas Drug Management System Market Size by Type (2020-2025)
5.3 Americas Drug Management System Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Management System Market Size by Region (2020-2025)
6.2 APAC Drug Management System Market Size by Type (2020-2025)
6.3 APAC Drug Management System Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Management System Market Size by Country (2020-2025)
7.2 Europe Drug Management System Market Size by Type (2020-2025)
7.3 Europe Drug Management System Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Management System by Region (2020-2025)
8.2 Middle East & Africa Drug Management System Market Size by Type (2020-2025)
8.3 Middle East & Africa Drug Management System Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Management System Market Forecast
10.1 Global Drug Management System Forecast by Region (2026-2031)
10.1.1 Global Drug Management System Forecast by Region (2026-2031)
10.1.2 Americas Drug Management System Forecast
10.1.3 APAC Drug Management System Forecast
10.1.4 Europe Drug Management System Forecast
10.1.5 Middle East & Africa Drug Management System Forecast
10.2 Americas Drug Management System Forecast by Country (2026-2031)
10.2.1 United States Market Drug Management System Forecast
10.2.2 Canada Market Drug Management System Forecast
10.2.3 Mexico Market Drug Management System Forecast
10.2.4 Brazil Market Drug Management System Forecast
10.3 APAC Drug Management System Forecast by Region (2026-2031)
10.3.1 China Drug Management System Market Forecast
10.3.2 Japan Market Drug Management System Forecast
10.3.3 Korea Market Drug Management System Forecast
10.3.4 Southeast Asia Market Drug Management System Forecast
10.3.5 India Market Drug Management System Forecast
10.3.6 Australia Market Drug Management System Forecast
10.4 Europe Drug Management System Forecast by Country (2026-2031)
10.4.1 Germany Market Drug Management System Forecast
10.4.2 France Market Drug Management System Forecast
10.4.3 UK Market Drug Management System Forecast
10.4.4 Italy Market Drug Management System Forecast
10.4.5 Russia Market Drug Management System Forecast
10.5 Middle East & Africa Drug Management System Forecast by Region (2026-2031)
10.5.1 Egypt Market Drug Management System Forecast
10.5.2 South Africa Market Drug Management System Forecast
10.5.3 Israel Market Drug Management System Forecast
10.5.4 Turkey Market Drug Management System Forecast
10.6 Global Drug Management System Forecast by Type (2026-2031)
10.7 Global Drug Management System Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Drug Management System Forecast
11 Key Players Analysis
11.1 Veradigm
11.1.1 Veradigm Company Information
11.1.2 Veradigm Drug Management System Product Offered
11.1.3 Veradigm Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Veradigm Main Business Overview
11.1.5 Veradigm Latest Developments
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Information
11.2.2 Becton, Dickinson and Company Drug Management System Product Offered
11.2.3 Becton, Dickinson and Company Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Becton, Dickinson and Company Main Business Overview
11.2.5 Becton, Dickinson and Company Latest Developments
11.3 GE Healthcare
11.3.1 GE Healthcare Company Information
11.3.2 GE Healthcare Drug Management System Product Offered
11.3.3 GE Healthcare Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GE Healthcare Main Business Overview
11.3.5 GE Healthcare Latest Developments
11.4 McKesson
11.4.1 McKesson Company Information
11.4.2 McKesson Drug Management System Product Offered
11.4.3 McKesson Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 McKesson Main Business Overview
11.4.5 McKesson Latest Developments
11.5 Oracle Health
11.5.1 Oracle Health Company Information
11.5.2 Oracle Health Drug Management System Product Offered
11.5.3 Oracle Health Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Oracle Health Main Business Overview
11.5.5 Oracle Health Latest Developments
11.6 Omnicell
11.6.1 Omnicell Company Information
11.6.2 Omnicell Drug Management System Product Offered
11.6.3 Omnicell Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Omnicell Main Business Overview
11.6.5 Omnicell Latest Developments
11.7 Chongqing Houjie Pharmaceutical Group
11.7.1 Chongqing Houjie Pharmaceutical Group Company Information
11.7.2 Chongqing Houjie Pharmaceutical Group Drug Management System Product Offered
11.7.3 Chongqing Houjie Pharmaceutical Group Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Chongqing Houjie Pharmaceutical Group Main Business Overview
11.7.5 Chongqing Houjie Pharmaceutical Group Latest Developments
11.8 Qingdao Yunuo Network Information
11.8.1 Qingdao Yunuo Network Information Company Information
11.8.2 Qingdao Yunuo Network Information Drug Management System Product Offered
11.8.3 Qingdao Yunuo Network Information Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Qingdao Yunuo Network Information Main Business Overview
11.8.5 Qingdao Yunuo Network Information Latest Developments
11.9 Guangzhou Yida Computer Technology
11.9.1 Guangzhou Yida Computer Technology Company Information
11.9.2 Guangzhou Yida Computer Technology Drug Management System Product Offered
11.9.3 Guangzhou Yida Computer Technology Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Guangzhou Yida Computer Technology Main Business Overview
11.9.5 Guangzhou Yida Computer Technology Latest Developments
11.10 Haihaidian Software
11.10.1 Haihaidian Software Company Information
11.10.2 Haihaidian Software Drug Management System Product Offered
11.10.3 Haihaidian Software Drug Management System Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Haihaidian Software Main Business Overview
11.10.5 Haihaidian Software Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂